STOCK TITAN

Ultragenyx to Host Conference Call for Third Quarter 2023 Financial Results and Corporate Update

Rhea-AI Impact
(Low)
Rhea-AI Sentiment
(Neutral)
Tags
conferences earnings
Rhea-AI Summary
Ultragenyx Pharmaceutical Inc. will host a conference call on November 2, 2023, to discuss its financial results and corporate update for Q3 2023.
Positive
  • Investors can gain insights into Ultragenyx Pharmaceutical's financial performance and corporate developments for Q3 2023 during the conference call.
Negative
  • None.

NOVATO, Calif., Oct. 26, 2023 (GLOBE NEWSWIRE) -- Ultragenyx Pharmaceutical Inc. (NASDAQ: RARE), a biopharmaceutical company focused on the development and commercialization of novel products for serious rare and ultrarare genetic diseases, today announced that it will host a conference call at 5:00 p.m. ET on Thursday, November 2, 2023, to discuss its financial results and corporate update for the quarter ending September 30, 2023.

The live and replayed webcast of the call will be available through the company’s website at https://ir.ultragenyx.com/events-presentations. To participate in the live call, please register by clicking on the following link (registration link) and you will be provided with dial-in details. The replay of the call will be available for one year.

About Ultragenyx Pharmaceutical Inc.
Ultragenyx is a biopharmaceutical company committed to bringing novel products to patients for the treatment of serious rare and ultrarare genetic diseases. The company has built a diverse portfolio of approved therapies and product candidates aimed at addressing diseases with high unmet medical need and clear biology for treatment, for which there are typically no approved therapies treating the underlying disease.

The company is led by a management team experienced in the development and commercialization of rare disease therapeutics. Ultragenyx’s strategy is predicated upon time- and cost-efficient drug development, with the goal of delivering safe and effective therapies to patients with the utmost urgency.

For more information on Ultragenyx, please visit the company's website at: www.ultragenyx.com.

Contact Ultragenyx
Investors & Media
Joshua Higa
(415) 475-6370


FAQ

When is Ultragenyx Pharmaceutical hosting a conference call?

Ultragenyx Pharmaceutical will host a conference call on November 2, 2023.

What will be discussed during the conference call?

The conference call will cover Ultragenyx Pharmaceutical's financial results and corporate update for the quarter ending September 30, 2023.

Where can I access the webcast of the call?

The live and replayed webcast of the call will be available through the company's website at https://ir.ultragenyx.com/events-presentations.

How long will the replay of the call be available?

The replay of the call will be available for one year.

Ultragenyx Pharmaceutical Inc.

NASDAQ:RARE

RARE Rankings

RARE Latest News

RARE Stock Data

4.01B
88.07M
3.62%
97.49%
3.62%
Biotechnology
Pharmaceutical Preparations
Link
United States of America
NOVATO